The short version of regulatory status fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-09-18. Anything still debated is marked as such rather than presented as settled.
Research on AOD-9604 also examines how the peptide is measured in biological samples. Analytical methods may include liquid chromatography coupled with mass spectrometry, immunoassays, or both. Detection can be challenging because the peptide is small and may be present at low concentrations. Published methods vary in sensitivity and specificity, so comparative interpretation requires attention to validation details. The presence of related hGH fragments can complicate identification in some matrices.
AOD-9604 has been investigated mainly in the context of body fat and metabolic endpoints. Some early animal and small human studies reported changes in fat mass or lipid markers, but findings were not uniform. Larger, well-controlled trials that would establish efficacy are lacking in the public literature. As a result, claims about weight loss or metabolic benefit remain investigational rather than established. The distinction between a research finding and a proven clinical outcome is central to discussing this peptide.
Regulatory bodies have taken different approaches to AOD-9604. It is not approved as a prescription medicine by major agencies such as the U.S. Food and Drug Administration or the European Medicines Agency. In sport, the World Anti-Doping Agency prohibits peptide hormones, growth factors, and related substances, and AOD-9604 has been treated as a prohibited substance. These regulatory decisions reflect concerns about safety, efficacy, and potential misuse rather than proof of benefit.
Laboratory studies have reported that AOD9604 can increase lipolysis and reduce lipid accumulation in fat cells. The precise molecular target remains uncertain, and the compound does not appear to activate the growth hormone receptor in the same way as full-length hGH. Proposed mechanisms include effects on beta-adrenergic signaling and enzymes involved in fatty acid synthesis, but these pathways are not firmly established. Because most evidence comes from cell and animal models, whether the same effects occur in humans is an open question.
Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved as a medicine | Major agencies have not authorized it for therapeutic use. |
| Anti-doping status | Prohibited in sport | Listed among peptide hormones and related substances. |
| Primary research area | Metabolic and body-composition effects | Studies often examine fat mass or lipid markers. |
| Human evidence | Limited and mixed | Public data do not establish clinical efficacy. |
| Analytical detection | LC-MS and immunoassays | Methods vary in sensitivity and validation. |
AOD-9604 is a synthetic peptide whose sequence is modeled on the C-terminal region of human growth hormone. Published descriptions commonly place it as a modified fragment corresponding to hGH amino acids 176–191, with a tyrosine residue added or retained at the N-terminus to support detection and handling. It is not intact growth hormone and lacks the full receptor-binding architecture of the parent protein. The molecule was developed as a research candidate for metabolic studies rather than as a replacement for growth hormone therapy. Its identity is defined by its amino acid sequence rather than by any single commercial preparation.
AOD-9604 drew attention in the 1990s and 2000s as a potential anti-obesity agent. Early work explored both injectable and oral routes, which is unusual for a peptide of this size. Animal studies reported changes in fat metabolism without the growth-promoting or insulin-like effects associated with full-length growth hormone. Subsequent human trials produced mixed or modest results, and the compound did not obtain regulatory approval for weight management in major markets. It remains known mainly through research literature, sports anti-doping listings, and non-approved supplement advertising.
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
Detection and characterization of AOD-9604 in research and anti-doping settings typically rely on mass spectrometry coupled with liquid chromatography. These methods can identify the peptide by its mass and fragmentation pattern. Immunoassays may also be used in some screening contexts, but they can cross-react with related peptides. Because the molecule is small and may be present at low concentrations, sample preparation and method validation are important. Confirmatory analysis usually requires comparison with a certified reference standard.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
== Definition == Natural uranium contains about 0.72% 235U. Depleted uranium has lower mass fractions—up to three times less—of 235U and 234U than natural uranium. Since 238U has a much longer half-life than the lighter isotopes, DU is about 40% less radioactive than natural uranium. Most of the alpha radiation comes from 238U and 234U whereas beta radiation comes from decay products 234Th and 234Pa that are formed within a few weeks. The United States Nuclear Regulatory Commission (NRC) defines depleted uranium as uranium with a percentage of the 235U isotope that is less than 0.711% by weight (see 10 CFR 40.4). The military specifications designate that the DU used by the U.S. Department of Defense (DoD) contain less than 0.3% 235U. In actuality, DoD uses only DU that contains approximately 0.2% 235U.
=== Interactions === Drugs that potentiate or prolong the effects of sulfonylureas and therefore increase the risk of hypoglycemia include acetylsalicylic acid and derivatives, allopurinol, sulfonamides, and fibrates. Drugs that worsen glucose tolerance, contravening the effects of antidiabetics, include corticosteroids, isoniazid, oral contraceptives and other estrogens, sympathomimetics, and thyroid hormones. Sulfonylureas tend to interact with a wide variety of other drugs, but these interactions, as well as their clinical significance, vary from substance to substance.
==== History ==== It was founded in March 1979 as part of the People's Liberation Army Basic Engineering Corps. It was under the joint dual command of the Basic Engineering Corps and the Ministry of Metallurgical Industry. It consisted of 7 regiment level battalions and 12 geological teams. The Gold Corps was handed to the PAP in January 1985. After 1985, it went under the dual control of the Ministry of Metallurgical Industry and Ministry of Public Security. Its role in this time was to do geological surveys for gold mining. After February 1999, it went under the dual control of the People's Armed Police and the State Economic and Trade Commission. Its official duties were: finding gold deposits, providing security and law enforcement to gold mines, mining gold and preventing conflict near gold mines. By 2011, the gold corps had mined 1800 tonnes of gold. The same year in December, its official role switched again to geological surveying and metal analysis along with disaster relief to geological related incidents and law enforcement. In 2016, its role was switched yet again to focus primarily on military geology related work in the Deepening National Defense and Military Reform. In 2018, the Gold Corps was disbanded and its personnel were handed to the Ministry of Natural Resources, the China Geological Survey and the China National Gold Group Corporation.
The size of a burn is measured as a percentage of total body surface area (TBSA) affected by partial thickness or full thickness burns. First-degree burns that are only red in color and are not blistering are not included in this estimation. Most burns (70%) involve less than 10% of the TBSA. Unit of measuring burns is VSD as 10% TBSA is equal to 1VSD. There are a number of methods to determine the TBSA, including the Wallace rule of nines, Lund and Browder chart, and estimations based on a person's palm size. The rule of nines is easy to remember but only accurate in people over 16 years of age. More accurate estimates can be made using Lund and Browder charts, which take into account the different proportions of body parts in adults and children. The size of a person's handprint (including the palm and fingers) is approximately 1% of their TBSA.
Sources: en.wikipedia.org
8 May Skipton Building Society becomes the first building society since the 2008 financial crisis to announce it will offer 100% mortgages, aimed at first-time buyers who cannot afford a deposit. Coronation of Charles III and Camilla: Official photographs of the King and Queen taken shortly after the Coronation ceremony are released. On the final day of celebrations, people are encouraged to get involved in the Big Help Out by joining volunteer projects across the UK. 9 May House of Commons Speaker Sir Lindsay Hoyle unveils two new stained glass windows at the Palace of Westminster. One featuring his new personal coat of arms, with a rugby league ball, bees and Lancashire roses. The other window celebrates Britain's Coat of Arms of all three Crown Dependencies and all sixteen British Overseas Territories. Hoyle said at the unveiling the windows were and "will forever be tangible reminders of the strong, close links between the United Kingdom, the overseas territories and the crown dependencies". A Freedom of Information request filed by The Guardian reveals that at least one baby has been born with the DNA of three people, with 0.1% of the third person's DNA used in an attempt to prevent children developing mitochondrial diseases. Addressing the issue of arrests made during the Coronation, Sir Mark Rowley, Commissioner of the Metropolitan Police, says it is unfortunate people were not allowed to protest, but that there was a credible threat to disrupt the ceremony.
=== Whole-mass determination === The protein’s whole mass is the sum of the masses of its amino-acid residues plus the mass of a water molecule and adjusted for any post-translational modifications. Although proteins ionize less well than the peptides derived from them, a protein in solution may be able to be subjected to ESI-MS and its mass measured to an accuracy of 1 part in 20,000 or better. This is often sufficient to confirm the termini (thus that the protein’s measured mass matches that predicted from its sequence) and infer the presence or absence of many post-translational modifications.
==== Prokaryotic regulation ==== Because of the vital role rRNA plays in the cell physiology of prokaryotes, there is much overlap in rRNA regulation mechanisms. At the transcriptional level, there are both positive and negative effectors of rRNA transcription that facilitate a cell's maintenance of homeostasis:
Sources: en.wikipedia.org
Since irregularities in the menstrual cycle are normal shortly after menarche and during perimenopause, the age of the individual and the time since menarche need to be taken into account. Menstrual cycles are considered irregular in the following cases:
On 9 July, Thom took Florey and Heatley to Washington, D.C., to meet Percy Wells, the acting assistant chief of the USDA Bureau of Agricultural and Industrial Chemistry and as such the head of the USDA's four laboratories. Wells sent an introductory telegram to Orville May, the director of the UDSA's Northern Regional Research Laboratory (NRRL) in Peoria, Illinois. They met with May on 14 July, and he arranged for them to meet Robert D. Coghill, the chief of the NRRL's fermentation division, who raised the possibility that fermentation in large vessels might be the key to large-scale production. On 17 August, Florey met with Alfred Newton Richards, the chairman of the Committee for Medical Research (CMR) of the Office of Scientific Research and Development (OSRD), who promised his support. On 8 October, Richards held a meeting with representatives of four major pharmaceutical companies: Squibb, Merck, Pfizer and Lederle. Vannevar Bush, the director of OSRD was present, as was Thom, who represented the NRRL. Richards told them that antitrust laws would be suspended, allowing them to share information about penicillin. This was not legalized until 7 December 1943, and it covered only penicillin and no other drug. OSRD arranged with the War Production Board (WPB) for them to have priority for equipment for laboratories and pilot plants.
On 26 September 1983, during the Cold War, the Soviet nuclear early warning system Oko reported the launch of one intercontinental ballistic missile with four more missiles behind it, from the United States. These missile attack warnings were suspected to be false alarms by Stanislav Petrov (1939–2017), an engineer of the Soviet Air Defence Forces on duty at the command center of the early-warning system. He decided to wait for corroborating evidence—of which none arrived—rather than immediately relaying the warning up the chain of command. This decision is seen as having prevented a retaliatory nuclear strike against the United States and its NATO allies, which would likely have resulted in a full-scale nuclear war. Investigation of the satellite warning system later determined that the system had indeed malfunctioned.
Sources: en.wikipedia.org
No. It is not approved as a therapeutic drug by major regulators. It is sold for research purposes in many settings, which is not the same as clinical approval.
It is classified among peptide hormones and related substances that are prohibited in sport. The ban reflects anti-doping rules rather than a judgment that the peptide is effective for performance enhancement.
Human studies are limited and have not produced consistent evidence of meaningful clinical benefit. Some early trials examined metabolic endpoints, but larger confirmatory trials are generally lacking.
AOD9604 is a synthetic peptide based on a C-terminal segment of human growth hormone. It is manufactured by chemical peptide synthesis rather than extracted from human tissue. The sequence is often described as hGH fragment 176–191 or a close variant.